Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2018/09/015832
CTRI/2018/09/015832
Recruiting
Phase 1

Transplantation of autologous iliac crest physeal chondrocytescultured in monolayer to treat Physeal bars in children

Department of Health Research0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- Limb deformity due to physeal damage caused by trauma or infectionHealth Condition 2: T758- Other specified effects of external causes

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Health Condition 1: null- Limb deformity due to physeal damage caused by trauma or infectionHealth Condition 2: T758- Other specified effects of external causes
Sponsor
Department of Health Research
Status
Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Department of Health Research

Eligibility Criteria

Inclusion Criteria

  • •The subject should
  • •Be of pediatric age group with a growth plate defect amenable to treatment
  • •Should have a definitive growth plate defect of 10 to 60% to on imaging MRI
  • •Should be Indian nationals and able to come for follow up regularly

Exclusion Criteria

  • •Subjects with chronic illness.
  • •Subjects on long term medications.
  • •Subjects with active infection and inflammation on the growth plate.
  • •Subjects not suitable for surgery due to any other reasons.
  • •Subject unable to come for a minimum of 2 years follow up.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 1
use of chondrocytes cells for for bone growth plate injury in childreHealth Condition 1: null- children with Physeal bars in boneHealth Condition 2: M891- Physeal arrest
CTRI/2012/05/002638Christian Medical College Vellore5
Active, not recruiting
Phase 1
Transplantation of Autologous Stem Cells for the treatment of corneal diseases
EUCTR2018-000523-14-ESniversidad Miguel Hernandez30
Active, not recruiting
Phase 1
Adipose Cell Derived Regenerative Endothelial and Angiogenic MedicinePatients with rest pain or ischemic ulcers/gangrene of the lower limb and without option for revascularization or poor option. Or patients with with rest pain or ischemic ulcers and persistent CLI after revascularization, or with severe cardiac, respiratory or renal disease who are at increased risk of complication from surgery or anesthesia, or with moderately severe or severe heart failure, severe or very severe Chronic Obstructive Pulmonary disease or severe renal disease.Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2018-000967-10-FRniversity Hospital Toulouse43
Completed
Not Applicable
Comparing the results of using strut bone graft from the iliac bone and cancellous bone graft from the iliac bone on large bone defects in the lower bodyPerforming autogenous strut bone graft in patients with large bone defects of = 5 cm in the lower extremities.Musculoskeletal Diseases
ISRCTN99236054Hanyang University Seoul Hospital50
Completed
Not Applicable
Effect of Autologous Adipose Tissue Derived Mesenchymal Stem Cells injection in Rotator Cuff DiseaseDiseases of the musculo-skeletal system and connective tissue
KCT0001523Seoul Metropolitan Government Seoul National University Boramae Medical Center18